Urinary miRNA in Endometrial Cancer Study
NCT03824613 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 164
Last updated 2021-03-01
Summary
This study is a prospective feasibility study with the addition of a retrospective cohort study on the the expression of microRNA in urine in endometrial cancer patients.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Urinary miRNA
MiRNA detection in urine
Sponsors & Collaborators
-
Royal Cornwall Hospitals Trust
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-03-08
- Primary Completion
- 2020-03-26
- Completion
- 2020-03-26
Countries
- United Kingdom
Study Locations
More Related Trials
-
miRNAs in High Grade Serous Ovarian Cancer
NCT05146505 ·Status: UNKNOWN
-
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
NCT03947346 ·Status: COMPLETED
-
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
NCT02253251 ·Status: RECRUITING
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING
-
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
NCT04406831 ·Status: RECRUITING
-
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
NCT06341855 ·Status: RECRUITING ·Phase: NA
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
NCT01703585 ·Status: COMPLETED
-
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
NCT06218433 ·Status: RECRUITING ·Phase: NA
-
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573 ·Status: UNKNOWN
-
Precision Medicine Applied to the Study of Endometrial Cancer: Application of NGS for Molecular Classification
NCT07006103 ·Status: NOT_YET_RECRUITING
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
NCT07224750 ·Status: RECRUITING
-
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 ·Status: COMPLETED
-
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00758056 ·Status: UNKNOWN
-
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
NCT05902494 ·Status: COMPLETED
-
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
NCT00582387 ·Status: COMPLETED
-
Vasculogenic Mimicry in Urothelial Carcinoma
NCT04295967 ·Status: UNKNOWN
-
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
NCT04015102 ·Status: COMPLETED
-
Predictors of Node Positivity in Endometrial Cancer
NCT05793333 ·Status: RECRUITING
-
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517 ·Status: RECRUITING
-
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NCT06489041 ·Status: RECRUITING ·Phase: NA
-
A Genotype-Phenotype Urothelial Cancer Registry
NCT00902590 ·Status: ACTIVE_NOT_RECRUITING
-
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
NCT05630131 ·Status: COMPLETED
-
Urine Methylation Markers in UTUC
NCT06805630 ·Status: RECRUITING ·Phase: NA
-
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
NCT06274541 ·Status: COMPLETED